United States · FDA National Drug Code directory
Carbidopa and Levodopa
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0378-0094_164375a9-db50-4cb3-86ca-a52a3e74cc83
- Product NDC
- 0378-0094
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- carbidopa and levodopa
- Labeler
- Mylan Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 19991006
- Source listing expiry
- 20271231
Source-listed ingredients
- CARBIDOPA — 50 mg/1
- LEVODOPA — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0378-0094-01) · 0378-0094-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →